MedPath

The effect of exercise on the Asprosin hormone in overweight and obese wome

Not Applicable
Conditions
Obesity and overweight.
Overweight and obesity
Registration Number
IRCT20160813029322N2
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

Age: 25-40 years
General physical and mental health
Body mass index (BMI) more than 25 kg / m 2
Not having regular exercise for 6 months before starting training
Not having diseases: cardiovascular, diabetes, hormonal disorders, kidney and liver diseases, surgery, tobacco use and any medical intervention

Exclusion Criteria

Participate in regular sports activities
Disease during exercise
Pregnancy during exercise
Refusing to continue cooperation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Six weeks, One sessions a week. Method of measurement: Heartbeat watch.;Maximum oxygen consumption. Timepoint: Six weeks, One sessions a week. Method of measurement: Treadmill.
Secondary Outcome Measures
NameTimeMethod
Asprosin. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Asprosin Kit (ELISA ng/ml).;Fat percentage (kg/m 2). Timepoint: Before the intervention and two months after the intervention. Method of measurement: Related formula BF% = (0.41563 * X) - (0.00112 * 2) X + (0.03663 * Y) +4.03653.
© Copyright 2025. All Rights Reserved by MedPath